Cargando…
Lung adenocarcinoma-specific three-integrin signature contributes to poor outcomes by metastasis and immune escape pathways
BACKGROUND: Inhibitors targeting integrins (ITGs) are applied as a novel strategy for cancers including lung cancer; however, the heterogeneity of ITG subunits might explain why ITG-targeted inhibitors only show limited efficacy for a small group of lung cancer patients. MATERIALS AND METHODS: RNA-S...
Autores principales: | Wang, Yizhe, Hou, Kezuo, Jin, Yue, Bao, Bowen, Tang, Shiying, Qi, Jianfei, Yang, Yang, Che, Xiaofang, Liu, Yunpeng, Hu, Xuejun, Zheng, Chunlei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sciendo
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802404/ https://www.ncbi.nlm.nih.gov/pubmed/35136724 http://dx.doi.org/10.2478/jtim-2021-0046 |
Ejemplares similares
-
Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
por: Cheng, Yang, et al.
Publicado: (2021) -
NPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer
por: Yan, Hongfei, et al.
Publicado: (2019) -
Integrin α5 promotes migration and invasion through the FAK/STAT3/AKT signaling pathway in icotinib-resistant non-small cell lung cancer cells
por: Yang, Yang, et al.
Publicado: (2021) -
Bioinformatics-Based Identification of HDAC Inhibitors as Potential Drugs to Target EGFR Wild-Type Non-Small-Cell Lung Cancer
por: Wang, Yizhe, et al.
Publicado: (2021) -
LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma
por: Wu, Jie, et al.
Publicado: (2021)